How bad is my prostate cancer??? We’ve all asked ourselves that! Today there are tests to predict its gravity early in the diagnosis and after surgery.
How do these tests work?
… what’s inside the ‘black box’ that makes it an accurate crystal ball?
… and are all tests born equal?
… the test manufacturers won’t say BUT one doc who will is Dr. Todd Morgan – he’s looked inside all of them.
Dr. Morgan is Chief Urologist at the University of Michigan and leads the MUSIC* program.
He will discuss:
the difference between inherited and somatic testing
who should undergo genomic testing
how tests are able to predict
his upcoming randomized trial comparing the leading genomic tests, Decipher, Prolaris, and Oncotype DX
… and more including your questions
* Michigan Urological Surgery and Improvement Collaborative
Dr. Morgan has served on several national guideline committees, including the American Urological Association’s Advanced Prostate Cancer Guidelines, the National Comprehensive Cancer Network’s Prostate Cancer Early Detection Guidelines, the American Society for Clinical Oncology’s Localized Prostate Cancer Guidelines, and the ASCO Molecular Markers for Prostate Cancer Guidelines.
Watch here:
Special thanks to Bayer, Pfizer, Myovant Sciences, Foundation Medicine, Myriad Genetics, Janssen – Johnson & Johnson, Telix, and Blue Earth Diagnostics for sponsoring this webinar.
For information on our peer-led video chat PROSTATE CANCER VIRTUAL SUPPORT GROUPS, click here.
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
Parp-Inhibitors have long been on AnCan’s radar since our dear departed Boardie, Dr. Bill Burhans, found himself with olaparib in his lab in 2015 and convinced his tumor board to prescribe it along with abiraterone for his BRCA2 mutation.
Question is …
What’s a PARP-Inhibitor, and what does it do?
Who benefits from a PARP?
Do PARP-I’s work for everybody?
How can a PARP-I be used for prostate cancer?
AnCan brings you two experts to discuss. Dr. Pamela Munster of the UCSF BRCA Research Institute with her unique peer perspective, and Dr. Neal Shore who just released the TALAPRO-2 Study using a PARP with Xtandi.
Watch here:
Special thanks to Bayer, Pfizer, Myovant Sciences, Foundation Medicine, Myriad Genetics, Janssen – Johnson & Johnson, Telix, and Blue Earth Diagnostics for sponsoring this webinar.
For information on our peer-led video chat PROSTATE CANCER VIRTUAL SUPPORT GROUPS, click here.
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
And when we say free, we mean that in addition to the lesson being free, the supplies will also be free, too!! We are SO happy that we are able to offer this class – especially because it will benefit a community of individuals that is much more in need of mental health benefits than they might realize.
Last day to register is June 19th. We want to make sure everyone receives their supplies on time!
Your instructor, Hannah Garrison, currently works with the VA hospital system in San Antonio, TX, as a creative arts instructor for their psychiatric units. She has been there to witness the incredible mental health benefits of a creative arts practice in the individuals she works with. We’re here to provide space for a community of like-minded individuals. Starting a new hobby can be intimidating, so that’s why we are so happy to be able to provide your supplies completely free.
PLEASE send this class registration to any and all Veterans you know, that may be interested.
We’ll be using watercolors and watercolor pencils! You’ll be receiving everything needed to complete this project in our class time – minus any napkins and water, of course.
Are you a Veteran in need of some virtual support? Whether you have chronic illness, cancer, mental health concerns, etc; we welcome you with open arms. We’re a virtual support group filled with other peers who have a lot of advice and support to offer.
Next meeting is June 22nd at 8pm ET / 5pm PT. Drop in HERE. No need to register.
Looking to make some art a little sooner? We have our next general art class on June 8th at 8pm ET! It’s free, and it’s BYOAS (Bring Your Own Art Supplies). We’re making an acrylic painting on canvas!
Hello friends! In case you missed April’s AnCan Friends Art Class, we wanted to share the recording with our amazing community. This project uses both crayons and watercolors for a crayon wax resist effect! Check it out below:
You’ll need crayons, watercolors, mixed media paper or watercolor paper, and either a round brush or a flat brush. I happened to use a size # 8 round brush.
In case you’re having trouble figuring out what colors to use, you’ll see a few different examples of paintings I’ve done in the past. Mostly I just had fun experimenting with the colors, and I hope you can do the same, too! We’re always so proud of the work that comes out of this class. Happy painting!!!
AnCan Foundation supports several conditions that compromise the pelvic floor as a result of surgery, radiation, or just side effects of the disease itself. It can impact continence and sexual function for all!
A non-interventional rehab solution is pelvic floor physical therapy – a sub-specialty in itself.
Join one of AnCan’s favorite superstars, urologist Dr. Rachel Rubin, and esteemed expert Dr. Tracy Sher. Together, shared how pelvic floor exercises can help you recover function!
You’ll also get a ton of questions answered, asked by MS Moderator Kim Stroeh, and Prostate Cancer moderator Dr. John Antonucci.
Watch here:
Special thanks to Bayer, Pfizer, Myovant Sciences, Foundation Medicine, Myriad Genetics, Janssen – Johnson & Johnson, and Telix for sponsoring this webinar.
Check back later for slides.
For information on our peer-led video chat VIRTUAL SUPPORT GROUPS, click here.
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
WEBINAR – ‘The Invasion of the Prostate Snatchers: 13 years Later’: An Evening with Dr. Mark Scholz
By Howard Wolinsky, Peter Kafka and Ben Nathanson
Dr. Mark Scholz, author of Invasion of the Prostate Snatchers, drew a record audience to his AnCan webinar on January 30, 2023.
Registration worldwide was close to 1,000 — nearly double the previous record — with more than 600 watching live.
Scholz’s talk, “Invasion of the Prostate Snatchers: 13 years later” discussed how prostate cancer treatment — and overtreatment — has progressed since the book’s original publication in 2010. The book took aim at a urological-industrial complex performing surgeries on hundreds of thousands of low-risk patients, leaving many impotent and incontinent.
Half those men, he argued, could safely have been followed without aggressive treatment. Scholz, a medical oncologist, coauthored the book with patient Ralph Blum. A new edition was issued in 2021.
While urologists today still unnecessarily “snatch” prostates, Scholz said, the number is far fewer since active surveillance was endorsed in 2007 as a safe and effective strategy. And he said radiation therapy, which he had criticized in the past, also has become safer and more effective.
Still, men come to him thinking they have only two options: surgery or radiation. In fact, they have more than a dozen options, based on the severity of their disease and their preferred balance of treatment and side effects. He urges patients to “obtain facts and apply principles” — replacing assumptions about cancer with informed decisions.
Even for the smaller, but significant segment of men diagnosed with more serious grades of prostate cancer including metastatic, Scholz explained that there has been so much progress in new treatment modalities with limited side effects that many men are living long productive lives living with their disease and not dying from prostate cancer. Dr. Scholz stressed that unlike other cancers, prostate cancer is much slower growing and the rush for treatment in most instances is not necessary.
After the talk, Scholz answered 40 minutes of audience questions.
AnCan moderator Joe Gallo produced the webinar, and moderators Peter Kafka, Howard Wolinsky, and Ben Nathanson relayed questions. Alexandra Scholz, CEO of Prostate Cancer Research Institute, the nonprofit education initiative run by Scholz, edited the video, and she and Peter Scholz lent production assistance.
